Table 2 Characteristics of risk factors and tests for detecting GDM defined as Model I^a(A), modified IADPSG criteri and Model II^b(B), HAPO data 2.0 OR criteria. 95% CI in parenthesis

≥ 4.4

(4.0)

49

96 (94–98)

57 (55–59)

23 (21–25)

99 (98–99)

77 (75–78)

≥ 4.6

(4.1)

41

95 (93–97)

67 (65–68)

28 (25–30)

99 (99–99)

81 (79–83)

≥ 4.8

(4.3)

24

91 (88–94)

85 (83–86)

44 (41–48)

99 (98–99)

88 (86–90)

≥ 5.0

(4.5)

14

89 (86–92)

96 (95–96)

73 (69–77)

99 (98–99)

92 (91–94)

16

28 (24–32)

86 (84–87)

20 (17–24)

90 (89–91)

43 (40–46)

19

36 (32–41)

84 (82–85)

23 (20–26)

91 (90–92)

40 (37–43)

≥ 4.4

(4.0)

49

96 (93–98)

54 (53–56)

14 (12–16)

99 (99–100)

75 (73–78)

≥ 4.6

(4.1)

41

96 (93–98)

64 (62–65)

17 (15–19)

100 (99–100)

80 (78–82)

≥ 4.8

(4.3)

24

93 (89–95)

81 (80–82)

28 (25–31)

99 (99–100)

87 (85–89)

≥ 5.0

(4.5)

14

91 (87–94)

92 (91–93)

46 (42–50)

99 (99–100)

91 (89–94)

≥ 5.2

(4.7)

8

89 (84–92)

98 (98–99)

78 (73–83)

99 (99–99)

94 (91–96)

16

31 (25–37)

85 (84–86)

14 (11–17)

94 (93–95)

42 (38–46)

19

41 (35–47)

83 (82–84)

16 (13–19)

95 (94–96)

38 (34–42)